Monoclonal antibodies (MAbs) raised against human T-cell lymphotropic virus type I (HTLV-I) recognized five distinct antigenic domains of viral env gene-encoded proteins. By using recombinant env proteins and synthetic peptides as mapping antigens, it was determined that the most immunogenic region represented a central portion of the retroviral surface protein (domain 2; amino acids 165 to 191). However, only a single MAb was able to react strongly with native viral proteins. This antibody (clone 6C2) was directed to an epitope within domain 4 (amino acids 210 to 306) of the retroviral env gene and reacted with envelope proteins in both HTLV-I and HTLV-ll, as determined by immunoprecipitation, solid-phase binding, and immunoblotting. No reactivity against envelope components of other human retroviruses, including human immunodeficiency virus types 1 and 2, was present. Flow cytometry data demonstrated that MAb 6C2 reacted with cell lines chronically infected with HTLV-I or HTLV-II and also with surface antigens expressed on fresh adult T-cell leukemia cells, following up-regulation with interleukin-2. By a chemiluminescence immunoassay procedure, picogram amounts of viral surface protein could be detected in the unconcentrated supernatants of HTLV-infected cell lines and in diagnostic cultures. Levels of env and gag proteins released by cells into culture supernatants were not directly related to percent expression of cell surface viral-coat proteins. Further, the molar ratio of p19 to gp46 in conditioned media varied from strain to strain, possibly reflecting differences in viral assembly or packaging mechanisms. MAb 6C2 will be of value in characterizing the biochemical and immunological behavior of retroviral env gene proteins and in studying the interaction of HTLV-I and HTLV-H with their receptors.
components of other human retroviruses, including human immunodeficiency virus types 1 and 2, was present. Flow cytometry data demonstrated that MAb 6C2 reacted with cell lines chronically infected with HTLV-I or HTLV-II and also with surface antigens expressed on fresh adult T-cell leukemia cells, following up-regulation with interleukin-2. By a chemiluminescence immunoassay procedure, picogram amounts of viral surface protein could be detected in the unconcentrated supernatants of HTLV-infected cell lines and in diagnostic cultures. Levels of env and gag proteins released by cells into culture supernatants were not directly related to percent expression of cell surface viral-coat proteins. Further, the molar ratio of p19 to gp46 in conditioned media varied from strain to strain, possibly reflecting differences in viral assembly or packaging mechanisms. MAb 6C2 will be of value in characterizing the biochemical and immunological behavior of retroviral env gene proteins and in studying the interaction of HTLV-I and HTLV-H with their receptors.
Human T-cell lymphotropic virus type I (HTLV-I) is associated with various forms of lymphoproliferation and leukemogenesis, including polyclonal lymphocytosis of T cells (44) , adult T-cell leukemia-lymphoma (ATL) (12, 42, 54) , and B-cell chronic lymphocytic leukemia (33) . Seroepidemiologic and molecular biology studies have also associated this viral infection with encephalomyeloneuropathies (2, 17, 20, 27) and polymyositis (53) . HTLV-I infections have been reported as the leading cause of hematopoietic neoplasms in Japan and in the Caribbean, where the rate of infection among asymptomatic individuals can be as high as 37% (3, 14, 18) . HTLV-I infections and associated leukemias may be more common in the United States than previously recognized (31, 35, 46) . In addition, infections with a related retrovirus, HTLV-II, have most recently been demonstrated at high prevalence within certain risk groups (10, 19, 26, 47) .
Envelope glycoproteins of animal and human retroviruses, encoded by the retroviral env gene, contain antigenic regions which play an important role in viral neutralization and also in determining the host range, strain specificity, and relative infectivity of the virus (1) . Evidence also suggests that the HTLV env glycoprotein may be a critical antigen for targeting by the host immune system. For example, the HTLV-I env glycoprotein is the major viral antigen recognized by antibodies in the sera of infected individuals (5, 8, 29, 37, 48) , and these antibodies are able to neutralize the infectivity of pseudotype virions which carry HTLV-I env proteins (6) . In other retroviral infections, particularly human immunodeficiency virus (HIV) infections, the most important neutraliz-* Corresponding author.
ing antibodies react with envelope proteins (for a review, see reference 4).
In order to further characterize the env gene products of HTLV-I, we have generated a panel of murine monoclonal antibodies (MAbs) to the surface protein of the virus. In addition to the capacity of these antibodies to identify various antigenic domains, one antibody (clone 6C2) was a sensitive probe for the detection of HTLV-I and HTLV-II env proteins on live cells and has also been utilized to construct a chemiluminescence immunoassay (CLIA) for the quantitative measurement of HTLV surface proteins.
MATERIALS AND METHODS
Abbreviations. Abbreviations used in this paper are as follows: BSA, bovine serum albumin; HIV type 1, HIV-1; IL-2, interleukin-2; mlg, nonimmune murine immunoglobulin; PBMC, peripheral blood mononuclear cells; PBS, 50 mM phosphate-0.9% sodium chloride (pH 7.2); PBS-M, PBS containing 5% (wt/vol) nonfat bovine milk solids; PBS-T, PBS containing 0.05% Tween 20; RIPA, radioimmunoprecipitation assay; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
Cell culture. Continuous cell lines were grown in RPMI 1640 medium containing 10% fetal bovine serum and antibiotics (complete medium). Cell-free culture supernatants were obtained at log phase of growth (0.8 x 106 to 1.2 x 106 cells per ml) by sedimentation of the cells at 5,000 x g; the supernatants were then filtered through 0.45-,um-pore-size filters. Viral cultures were done as described previously (38) .
Recombinant proteins. Escherichia coli-expressed recombinant proteins from the HTLV-I env gene were obtained (34) at Multiple Peptid precise location of each peptide within ti is shown in Fig. 1 Immunofluorescence phenotyping. Surface-marker phenotyping was performed as previously described (52) . Immunofluorescence was expressed as percent positive cells after subtraction of background staining with mlg.
HTLV-I p19 antigen quantitation. Measurements of HTLV-I p19 (viral matrix protein) were performed by antigen capture immunoassay, as described previously (38) , with commercial reagents (Retro-Tek HTLV-I Antigen ELISA kit; Cellular Products, Inc.). This immunoassay is HTLV-I specific and does not cross-react with HTLV-II (38) . 
RESULTS
Antigenic domains of HTLV-I envelope proteins. Hybridoma antibodies were screened for immunoreactivity against recombinant HTLV-I env proteins RE-1, RE-3, and RE-5 ( Fig. 1) . For comparison, a reference MAb was incorporated into the experimental scheme. This antibody, lCll, has been shown to identify domain 3 ( Fig. 1) of the HTLV-I gp46 molecule (37) . Of the 10 experimental hybridomas studied, 1 (clone 4B1) reacted solely with protein RE-1, 1 (clone 6C2) reacted solely with RE-3, and 1 (clone 64A) reacted solely with protein RE-5 (Table 1 ). In contrast, 7 of the 11 hybridomas reacted with both RE-1 and RE-3 proteins. This indicated a high degree of immunogenicity within the overlap region of these recombinant proteins (i.e., amino acids 165 to 209).
To further resolve the RE-1-RE-3 overlap region identified above, competition analyses with synthetic peptides were performed. The synthesized peptides completely spanned the overlap region and represented antigenic domains 2 and 3 ( Fig. 1) . Peptide CP-12 at a dose of 10 ,ug completely inhibited the immunoreactivity of reference MAb lC1l, corroborating previous data with synthetic peptide 4A (37) . In contrast, the antigen-binding activity of none of the seven experimental MAbs which interacted with the RE-1-RE-3 overlap region was perturbed in the presence of peptide CP-12. However, the immunological activity of each of these antibodies was neutralized in the presence of 10 ,ug of peptide CP-11, which corresponds to the upstream region of the RE-1-RE-3 overlap domain (i.e., amino acids 165 to 191) ( Fig. 1 (Fig. 2) .
Antigenic specificity of MAb 6C2. In direct-binding immunoassays, MAb 6C2 strongly reacted with recombinant HTLV-I env protein RE-3, derived from the C-terminal portion of gp46 (Fig. 3A) niques. As seen in Fig. 4 , the antibody precipitated proteins between 46 and 60 kDa from HTLV-I-and HTLV-II-infected cells. The presence of mature viral surface protein, gp46, was best resolved in the HUT-102 cell line (Fig. 4) . Specifically immunoprecipitated proteins were not detected from uninfected T-cell lines (CEM and HUT-78) or in cells infected with HIV-1 or HIV-2.
Reduced and denatured viral proteins which reacted with MAb 6C2 were detected by immunoblotting. Immune reactions with viral surface proteins from both HTLV-I and HTLV-II were observed. As shown in Fig. 5 on the cell surface (6C2-gp46 complex) was examined by staining HUT-102 cells with saturating doses of MAb 6C2, washing away excess MAb, and incubating the cells at 37°C for 20 h. After the incubation, the cells were probed with fluoresceinated caprine F(ab')2 anti-murine Ig to detect surface-bound MAb 6C2. Additional MAb 6C2 was added to a separate aliquot of pretreated cells to determine whether free MAb 6C2 binding sites were available (Fig. 6) (antigenic modulation) and that additional viral surface proteins were rapidly expressed.
Cell surface binding of the antibody was HTLV group specific, as further determined by cytofluorographic examination of a panel of cell types. As shown in Table 2 (Fig. 7A) . With this immunoassay, HTLV env proteins in neat culture fluids were easily detectable (Fig. 7B ). As shown in Table 2 (Table 2) . Moreover, for cells infected with prototype HTLV-I strains, the ratio of supematant gp46 and p19 varied from strain to strain, although p19 protein was found in much larger amounts than gp46. In contrast, fresh ATL cells produced the highest levels of gp46 while producing only modest levels of p19 (Table 2) . DISCUSSION HTLV env gene-encoded proteins were detected with MAb 6C2. The antibody was shown to be HTLV specific by the following criteria: (i) antigen was specifically expressed on cell surfaces of HTLV-I-and HTLV-II-infected cell lines, including lymphokine-stimulated ATL PBMC; (ii) antigen was detected in sucrose-banded HTLV-I and HTLV-II but not in HIV-1 or HIV-2 preparations; (iii) recombinant proteins from the HTLV-I env gene were immunoreactive, compared with recombinant protein derived from the viral gag gene; (iv) the structural identity of native and denatured proteins detected by the antibody corresponded to viral envelope glycoproteins as described in detail earlier (25, 29, 30, 36 At the secondary level, enzyme immunoassay to p19 matrix protein can be performed. As shown previously, the p19 assay is HTLV-I specific and can be of value in the differential diagnosis of HTLV-II infection (38) . Inasmuch as some patients with HTLV-I infection may be seronegative (9) , improving the clinical yield of diagnostic viral cultures will become increasingly important.
Results from cell staining and antigen quantitation assays revealed a qualitative relationship between surface antigen and extracellular viral protein. However, a quantitative relationship between levels of cell surface viral protein and amounts of viral gag and env proteins which were shed into the culture supernatants was not demonstrated. This may reflect cell-to-cell differences in viral processing, relative efficiency of viral packaging mechanisms, or qualitative differences in the ratio of env and gag moieties of the released virions (i.e., defective virus). Relatedly, fresh ATL cells produced levels of gp46 much higher than those observed for prototype strains of HTLV-I, including HUT-102, MT 
